Live from the NIH registry
Studies recruiting near Columbus right now
Top 25 of 1,340 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Nationwide Children's Hospital — Columbus, Ohio (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 208 participants sought
Ohio State University Comprehensive Cancer Center — Columbus, Ohio (1.9 mi)
· Sponsor: Ohio State University Comprehensive Cancer Center
Cardiothoracic Critical Care as Subspecialty and Its Core Competencies
Consensus Development
N/A
Observational 68 participants sought
The Ohio State University Wexner Medical Center — Columbus, Ohio (1.9 mi)
· Sponsor: Ohio State University
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Nationwide Children's Hospital — Columbus, Ohio (1.9 mi)
· Sponsor: Nationwide Children's Hospital
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Ohio State University Comprehensive Cancer Center — Columbus, Ohio (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Diabetes Mellitus, Type 2
N/A
Interventional 119,680 participants sought
The Ohio State University — Columbus, Ohio (1.9 mi)
· Sponsor: Stanford University
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Columbus, Ohio (1.9 mi)
· Sponsor: AstraZeneca
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
The Ohio State University, Energy Advancement and Innovation Center — Columbus, Ohio (1.9 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0015) — Columbus, Ohio (1.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Ohio Gastroenterology group, Inc. — Columbus, Ohio (1.9 mi)
· Sponsor: Takeda
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Ohio State University Comprehensive Cancer Center — Columbus, Ohio (1.9 mi)
· Sponsor: NRG Oncology
A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Multiple Myeloma
N/A
Interventional 90 participants sought
Ohio State University Comprehensive Cancer Center — Columbus, Ohio (1.9 mi)
· Sponsor: Ohio State University Comprehensive Cancer Center
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
OSU Wexner Medical Center — Columbus, Ohio (1.9 mi)
· Sponsor: Nurix Therapeutics, Inc.
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Thrombocythemia, Essential, Primary Myelofibrosis
Phase 3
Interventional 400 participants sought
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) — Columbus, Ohio (1.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
COPD, Chronic Obstructive Pulmonary Disease
N/A
Interventional 200 participants sought
Ohio State University Medical Center - Ohio State Lung Center — Columbus, Ohio (1.9 mi)
· Sponsor: Nuvaira, Inc.
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8
Phase 3
Interventional 250 participants sought
Ohio State University Comprehensive Cancer Center — Columbus, Ohio (1.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
The Ohio State University (OSU) — Columbus, Ohio (1.9 mi)
· Sponsor: Synairgen Research Ltd.
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor
Phase 1
Interventional 104 participants sought
Research Facility — Columbus, Ohio (1.9 mi)
· Sponsor: RayzeBio, Inc.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T — Columbus, Ohio (1.9 mi)
· Sponsor: Eli Lilly and Company
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
The Ohio State University — Columbus, Ohio (1.9 mi)
· Sponsor: Duke University
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Ohio State University — Columbus, Ohio (1.9 mi)
· Sponsor: Calliditas Therapeutics AB
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Bladder Cancer, Recurrent Bladder Cancer
N/A
Observational 408 participants sought
The Ohio State University — Columbus, Ohio (1.9 mi)
· Sponsor: University of Washington
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
OSU Wexner Medical Center — Columbus, Ohio (1.9 mi)
· Sponsor: Joseph Broderick, MD
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Nationwide Children's Hospital — Columbus, Ohio (1.9 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Columbus, Ohio (1.9 mi)
· Sponsor: AstraZeneca